跳至主要内容
临床试验/NCT03571074
NCT03571074已完成不适用

Hyperoxia Before and After Cardiac Arrest and Myocardial Damage, a Retrospective Cohort Study

University Hospital Bispebjerg and Frederiksberg1 个研究点 分布在 1 个国家目标入组 163 人开始时间: 2018年5月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
163
试验地点
1
主要终点
Peak troponin within 30 days after cardiac arrest

研究概览

简要总结

Several studies show how patients with hyperoxia after cardiac arrest has increased mortality, but the association of hyperoxia before cardiac arrest and myocardial damage has never been investigated. Neither has the association between hyperoxia after cardiac arrest and myocardial injury.

Our research hypothesis is that hyperoxia before cardiac arrest aggravates myocardial damage, secondly we wish to analyze the association between hyperoxia after cardiac arrest and myocardial injury.

The exposure variables is oxygenation within 48 hours before and 48 hours after cardiac arrest, our primary outcome is myocardial damage and will be measured as peak troponin within 30 days after cardiac arrest.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years or older
  • With a record of ICD-10 diagnosis of cardiac arrest in 2014, admitted to a hospital in the Capital Region of Denmark.
  • First recorded cardiac arrest in 2014
  • Admitted to ICU
  • Serum troponin measured within 7 days after cardiac arrest

排除标准

  • Out of hospital cardiac arrest, OHCA
  • In of hospital cardiac arrest, IHCA, but with no registered saturation before cardiac arrest.

结局指标

主要结局

Peak troponin within 30 days after cardiac arrest

时间窗: 30 days

Troponin measurements on patients after cardiac arrest.

次要结局

  • Troponin area under the curve within 3 days after cardiac arrest(3 days)
  • 30-day and 1-year mortality(Up to 1 year.)
  • Length of ICU stay after cardiac arrest(through study completion,on average of 4-8 weeks.)
  • Length of hospital stay after cardiac arrest(through study completion,on average of 4-8 weeks.)

研究者

发起方
University Hospital Bispebjerg and Frederiksberg
申办方类型
Other
责任方
Principal Investigator
主要研究者

Kathrine Schmidt Groenbek

Research Assistant, Bispebjerg Hospital.

University Hospital Bispebjerg and Frederiksberg

研究点 (1)

Loading locations...

相似试验